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Abstract
The association of bioactive molecules, such as vascular endothelial growth factor (VEGF), with nanofibers facilitates their
controlled release, which could contribute to cellular migration and differentiation in tissue regeneration. In this research, the
influence of their incorporation on a polylactic-co-glycolic acid (PLGA) scaffold produced by electrospinning on cell adhesion
and viability and cytotoxicity was carried out in three groups: 1) PLGA/BSA/VEGF; 2) PLGA/BSA, and 3) PLGA. Morphology,
fiber diameter, contact angle, loading efficiency and controlled release of VEGF of the biomaterials, among others, were
measured. The nanofibers showed smooth surfaces without beads and with interconnected pores. PLGA/BSA/VEGF showed
the smallest water contact angle and VEGF released for up to 160 h. An improvement in cell adhesion was observed for the
PLGA/BSA/VEGF scaffolds compared to the other groups and the scaffolds were non-toxic for the cells. Therefore, the scaffolds
were shown to be a good strategy for sustained delivery of VEGF and may be a useful tool for tissue engineering.
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Introduction
The fundamental concept of tissue engineering (TE)
involves the association of three basic requisites: 1) cellular
therapy, in which cells are planted in a damaged tissue or
in the circulatory system; 2) bioactive agents, including
signaling molecules and growth factors; 3) use of scaffolds
for cell support. These scaffolds allow the permeation of
nutrients and the elimination of residues, as well as the
localization of the cells on the lesion site (1).
In general, the substitution of damaged or non-functioning
tissue through the use of tissue developed in vitro requires
the concomitant formation of new blood vessels that are
able to provide oxygen and nutrients for the neoformed
tissue, a phenomenon called angiogenesis (2). Various
strategies are currently in use with the aim of increasing
the vascularization of the implants used in TE (3-6). Notable
among these is the addition of growth factors (GFs), such
as vascular endothelial growth factor (VEGF) in polymeric
biocompatible and biodegradable matrices (4,7). The
sequence of events during angiogenesis includes the
dilation of blood vessels through the movement of the
endothelial cells and the action of the proteolytic enzymes
together with cellular migration and proliferation. This process
is mainly controlled by the different VEGF isoforms (8).
Therefore, because of the great importance of angiogen-
esis in TE, the present study aimed to produce polymeric
scaffolds with incorporated VEGF, evaluating their mechan-
ical and physicochemical properties, and their influence on
the cultivation of mesenchymal stem cells. The future
objective is to contribute to the increase of vascularization
in models of GF controlled release, which can be applied
in tissue engineering.
Material and Methods
Preparation of polymer solutions
The PLGA/BSA/VEGF scaffolds were produced by
emulsification as follows: an organic phase, consisting of
15% PLGA (polylactic-co-glycolic acid) (w/w), 0.2% Span-80
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and 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP; Sigma-Aldrich,
USA), and an aqueous phase consisting of 0.1% bovine
serum albumin (BSA), 5% PBS and VEGF. The GF was
added in the aqueous phase at a final concentration of
1 mg/mL. The PLGA/BSA scaffolds were constructed simi-
larly, except for the presence of VEGF. The control group
was produced with PLGA at a concentration of 13% (w/w)
using HFIP (Sigma-Aldrich).
This study was approved by the Research Ethics
Committee of the Hospital Santa Casa de Misericórdia de
Porto Alegre (No. 3500/11).
Electrospinning
The polymer scaffolds were produced by the electro-
spinning technique (ES). The voltage for the PLGA/BSA/
VEGF and PLGA/BSA solutions was 18 kV, using an inner
needle diameter of 0.80 mm and a flow rate of 0.28 mL/h.
The distance between the needle and collector for both
solutions was 20 cm. For the 13% PLGA solution, the
voltage was 16 kV, using a 0.80 mm inner needle diameter
with a flow rate of 0.28 mL/h and a distance between the
needle and collector plate of 15 cm. The nanofiber
scaffolds were adhered onto 1.5 cm2 diameter coverslips
and sterilized with UV light for 1 h on a 24-well plate in a
laminar flow hood.
Human adipose derived stem cells (hADSCs) isolation
and cell culture
hADSCs were obtained from elective liposuction
procedures. Adipose tissue was subjected to enzymatic
treatment with 0.075% collagenase type I at 37°C for
30 min. The hADSCs were seeded in culture bottles of
25 cm2. The medium was replaced after 24 h in order to
isolate adherent cells, and thereafter it was refreshed
once every 3 days to allow further growth; the cells were
maintained at 37°C in a humidified atmosphere containing
5% CO2 until they reached 90% confluence. The cells
were expanded to the fifth passage, at which the biological
assays were performed.
Characterization assays
Characterization consisted of differentiation in adipo-
cytes, chondroblasts and osteoblasts, using a protocol
already established in the laboratory (9). The immu-
nophenotypic profile was analyzed using the antibo-
dies CD14, CD34, CD44, CD45, CD73, CD90, CD146,
CD184, Stro-1 and HLA-DR (Becton Dickinson, USA)
conjugated with FITC or PE fluorochrome. Appropriate
isotype controls were used and exclusion of dead
hADSCs was performed by incubation with 7-aminoac-
tinomycin D (7AAD). The analyses were performed
on flow cytometer FACSAria III (Becton Dickinson)
and analyzed by FACSDiva software, version 6.0.
The graphs were created with WinMDI, version 2.8
(The Scripps Institutes - Flow Cytometry Core Facility,
USA).
Morphology, fiber diameter and pore size
The assessment of nanofiber morphology was per-
formed by scanning electron microscopy (SEM), model -
JSM 6060 (JEOL, Japan). The images were obtained
using accelerating voltage of 10 kV. The diameters of the
fibers were evaluated by ImageJ 1.38x software (NIH,
USA) by measuring 30 fibers of each image obtained. The
estimation of the pore size was performed using the same
software. Ten pores of each image were analyzed by two
measurements in opposite directions from each portion.
Residual solvent content
The solvent content was evaluated by thermogravi-
metric analysis. The three groups of scaffolds were subjected
to a heating ramp of 10° to 500°C/min. The equipment
used was SDT Q600 (TA Instruments, USA).
Degradability
The molecular weight of the degradation products
was determined by gel permeation chromatography on
the chromatograph Viscotek GPCmax VE2001 (Malvern
Instruments, United Kingdom). The degradability test was
conducted simulating physiological conditions at 37°C in
PBS, pH 7.4. Approximately 30 mg of the scaffolds from
each group were submerged in 10 mL of PBS at 120 rpm,
at 37°C. Degradability was evaluated at the following
times: 0 (scaffolds not subjected to degradability), 7, 14,
and 30 days.
Mechanical properties characterization
Young’s modulus, maximum load and elongation of
the scaffolds were determined by dynamic mechanical
analysis (DMA; n=5) (Q800AT DMA instrument equipped
with a tension film clamp in the DMA controlled force
mode, TA instruments, EUA). The scaffolds were cut in a
rectangular shape (5 12 mm). The assays were carried
out with constant temperature (37°C) with a ramp force 0.5
N/min to 18 N maximum load, under 0.005 N static load.
Contact angle with water
Contact angle analysis was performed on five samples
of each type of scaffold (PLGA/BSA/VEGF, PLGA/BSA,
and 13% PLGA). A drop of water was instilled on the
surface of the scaffold with the aid of a syringe and a
photo was then taken at four different times: 5 and 30 s,
and 1 and 2 min. Using the software Surftens 3.0 (OEG,
Germany), at least three measurements of each picture
were taken by using five measurement points arranged
around the drop.
The contact angle of the films produced by the tested
polymer solutions were also evaluated. For the production
of polymer films, the different solutions were placed into
petri dishes and subsequently stored for 24 h in a desiccator
subjected to vacuum. In this experiment, a drop was
instilled into three different points on the surface of each
film, generating three images of each point. The assay
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was performed on four films of polymeric solutions, made
on different days.
Evaluation of VEGF incorporation efficiency
The PLGA/BSA/VEGF scaffolds were immersed in
30 mL of a dissolving solution (5 M urea; 0.1 NaOH;
0.08% SDS; 50 mM Tris) adapted from Sahoo et al. (10).
They were maintained in agitation at 140 rpm for 3.5 h,
with complete dissolution. After this period, all the volume
was removed and the VEGF dosage was performed.
Incorporation efficiency was calculated from the initial
amount of VEGF added to the emulsion (1 mg of VEGF to
2 g of polymer solution), compared to the final amount of
VEGF obtained after the dissolution of the matrices.
Quantification of the VEGF concentration was performed
by ELISA (ELISA Kit Human VEGF, Invitrogens, USA)
and absorbance was read in the spectrophotometer (450
nm) (Wallac EnVision, Perkin Elmer, USA).
Evaluation of VEGF release
For evaluation of VEGF release from PLGA/BSA/
VEGF matrices, approximately 200 mg (0.192±0.016 mg)
of the scaffolds were immersed in 10 mL of DMEM
containing 1% penicillin/streptomycin and fungizone. The
same assay was performed for the PLGA/BSA scaffolds
as negative control to evaluate the absence of a false
positive detection of VEGF due to the constituents of the
matrices. This was accomplished by placing the scaffolds
under agitation at 120 rpm at 37°C. The concentration of
VEGF was evaluated by ELISA (ELISA Kit Human VEGF,
Invitrogens) at intervals of 2, 8, 24, 72, 168, 336, and
504 h. In each of those periods, the total volume of DMEM
was removed and the VEGF level was evaluated. The
mediums were then renewed with 10 mL of DMEM and
maintained under agitation, with subsequent measure-
ments taken until the final time (504 h). Absorbance was
analyzed identically to the VEGF incorporation efficiency
test. The results are reported as percentage of cumulative
release.
Evaluation of HFIP solvent toxicity
In order to assess the potential toxicity of the solvent
HFIP, 45,000 hADSCs were cultured per well and different
concentrations of HFIP solvent (10, 50, 100, 250, and
500 ppm) in DMEM supplemented with 10% FBS and 1%
antibiotic were evaluated. In addition, a control group
without the addition of the solvent HFIP (0 ppm) was
evaluated. After 72-h cultivation, 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide assay (MTT; Sigma-
Aldrich) was performed to verify cell viability. The tests
were performed in triplicate (n=3).
Cellular adhesion assay
For this assay, 30,000 hADSCs were seeded on different
types of scaffolds and compared to the control group,
which consisted of cells cultivated directly on the plastic
surface of culture plates. Five different primary cultures
of hADSCs were used and all the experiments were
performed in triplicate. In the experiment, the cells were
stained with 4.6-diamidino-2-phenylindole (DAPI), a marker
of cell core, after 6 h of seeding on the scaffolds. Following
this, photographs were taken in 9 points randomly chosen
on the scaffolds and the average of cells per scaffold type
was calculated. The result is reported as a mean number
of cells.
Cellular viability assay
Cell viability on the scaffolds was assessed by the
colorimetric assay MTT (Sigma-Aldrich). The measure-
ments were taken in triplicate on days 1, 4, 7, 14, and
21 after seeding the cells onto both the scaffolds and the
wells (control group; n=5). After each time point, the cells
were incubated with 0.25 mg/mL MTT for 2 h. Four
hundred microliters of dimethylsulfoxide (DMSO) was
then added per well to dissolve the crystals formed.
Absorbance was measured at 560 and 630 nm. The
results were calculated by the absorbance label subtrac-
tion (560–630 nm) and reported as the average absor-
bance for each group. The absorbance measurement
was performed with the Wallac EnVision equipment
(Perkin Elmer).
Cytotoxicity assay
Cytotoxicity was assessed by measurement of the
enzyme lactate dehydrogenase (LDH; Labtest, Brazil).
Aliquots of the supernatant of the cultures were measured
after 4, 7, 14, and 21 days of cultivation. As negative
control, the cells cultured directly on the wells were used.
The positive control consisted of cells on the wells treated
with 1% (v/v) Triton X-100 (Sigma-Aldrich) for 10 min.
Absorbance was measured using the equipment Wallac
EnVision equipment (Perkin Elmer).
Statistical analysis
The results for the adhesion assay, cytotoxicity and
cell viability are reported as means±SE. The other results
are reported as means±SD. The cell viability, the
cytotoxicity assay and the contact angle were evaluated
by repeated measures analysis with two factors: time and
group (Hotelling) and Bonferroni post-test. Adhesion tests
were evaluated by ANOVA (one-way) and Tukey’s test
was used for the post-test. The results were generated by
SPSS 16 software (IBM, USA).
Results
The cells obtained through liposuction aspirates were
isolated, cultivated and characterized successfully. They
presented typical morphology of mesenchymal stem cells
(MSCs) in cultivation in vitro and were differentiated with
success into adipocytes, chondrocytes and osteocytes
(Figure 1). The cells presented high positivity for the
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following expressions: CD29 (98.2±1.1%), CD44 (76.65±
2.55%), CD73 (83.2±15%), and CD90 (90.05±8.65%).
Some antigens presented low expression: CD34 (3.15±
1.75%), CD184 (0.6±0.6%), and STRO-1 (2.8±2.5%)
and others presented negative expression: CD14, CD45
and HLA-DR.
The three groups of scaffolds presented well-formed
and randomly distributed fibers without beads and with
interconnected pores (Figure 2). The diameters of the
fibers were 588±123 and 554±164 nm for the PLGA/
BSA/VEGF and 13% PLGA matrices, respectively. The
PLGA/BSA group presented an average fiber diameter of
520±131 nm and were statistically different from the other
groups with Po0.05 for the PLGA/BSA/VEGF scaffolds
and Po0.001 for the 13% PLGA scaffolds.
The values for the pore size were 4.96±1.78,
4.56±2.03, and 5.01±2.19 mm for the PLGA/BSA/VEGF,
PLGA/BSA and 13% PLGA scaffolds, respectively. No
statistical difference was observed among the groups
(P=0.551).
During the 30 days of analysis, there was a degrada-
tion rate of approximately 25% for the PLGA/BSA/VEGF
group, 22% for the PLGA/BSA group and 13% for the 13%
PLGA matrices. There was no statistical difference in the
temporal analysis between the groups at any period of
evaluation (P= 0.956; Figure 3A).
The contact angle was evaluated in the three types of
scaffold produced by ES. The results obtained are shown
in Table 1.
The contact angle was also analyzed in polymeric film
produced from the PLGA/BSA/VEGF, PLGA/BSA emul-
sions and the 13% PLGA polymeric solution. The three
types of film produced presented hydrophilic profiles with
contact angles below 90°. The films produced from the
PLGA/BSA/VEGF solution presented greater hydrophilic
profiles with a contact angle of 55.22±3.22°. This was
statistically lower (P=0.037) than the angle encountered in
the PLGA 13% film, which was 62.73±4.66°. The PLGA/
BSA films presented an intermediate contact angle of
61.72±4.3°, which did not demonstrate a statistical
difference in relation to the other groups (P40.05 for all
comparisons; Figure 3B).
Young’s modulus and the maximum tensile strain of
the PLGA/BSA/VEGF scaffolds were 25.3±5.59 and
2.2±0.13, respectively. The PLGA/BSA scaffolds pre-
sented an average Young’s modulus of 20.4±5.02 and
maximum tensile strain of 2.4±0.44. The 13% PLGA
scaffold group presented values of 15.41±5.41 and
Figure 1. Differentiation of the human adipose derived stem cells. A, Condrogenic differentiation with Alcian Blue dye; B, osteogenic
differentiation with Alizarin Red dye; C, adipogenic differentiation with Oil Red dye; D, non-differentiated cells not submitted to dying with
typical morphology of mesenchymal stem cells. Images A, B and D with 200 magnification and image C with 400 magnification.
Scale bars: 50 mm.
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1.5±0.20 for Young’s modulus and maximum tensile
strain, respectively. Rupture did not occur in any of the
samples.
The values were greater for both Young’s modulus and
maximum tensile strain in the PLGA/BSA/VEGF scaffolds
compared to the 13% PLGA control (P=0.005 and P=
0.027, respectively). The PLGA/BSA scaffolds presented
intermediate values for Young’s modulus with no statis-
tical difference in relation to the other groups; however,
this same group presented a maximum tensile strain
greater than the 13% PLGA group (P=0.01) and obtained
no statistical differences in relation to the PLGA/BSA/
VEGF scaffolds (P=0.525) (Figure 3C and D).
Verification of the residual solvent content was performed
using thermogravimetric analysis. The results of this analysis
can be observed in Figure 4A. The weight loss in relation
to the three scaffold groups occurred between 50° and
75°C. The values for weight loss and the residual solvent
content can be seen in Table 2.
The incorporation rate of the growth factor into the
PLGA/BSA/VEGF scaffold was 3.47±0.96% (n=3). Of the
total amount of VEGF incorporated in the fiber, there was
an average liberation of 91.37% in a period of 504 h
(21 days; n=3). A liberation burst was observed in the
first 8 h, with a steep increase up to 72 h when it reached
a plateau (Figure 4B).
After 72 h of cultivation of the hADSCs in a culture
medium containing HFIP solvent, no statistical difference
was observed (P=0.929) in the various concentrations of
the tested HFIP (Figure 5A).
The cells demonstrated a higher adhesion tendency
although there was no statistical difference (P=0.490) in
the PLGA/BSA/VEGF scaffolds compared to the other two
scaffold groups (PLGA/BSA e PLGA 13%) and the control
(cells cultivated directly on the wells) (Figure 5B).
Cell viability for the PLGA/BSA/VEGF, PLGA/BSA and
13% PLGA groups over the 5 evaluated periods did not
present any statistical differences (P=0.916). The control
group presented the highest number of viable cells compared
to the other groups for all the periods of analysis (Po0.001;
Figure 6). However, between the 21st and the 1st day of
analysis, the following proliferation rates for the scaffolds
were observed: 2.23 for the PLGA/VEGF/BSA, 2.16 for the
PLGA/BSA, 2.05 for the 13% PLGA and 1.55 for the control.
The dosage of LDH for the three scaffold groups
were similar to the negative control group (P=1.000 for all
comparisons). The scaffolds continued to present dosages
of LDH well below the Triton 1% group (positive control),
which present a maximum liberation of LDH, or, in
other words, total cell death (Figure 7; Po0.003 for all
comparisons).
Discussion
The choice of the biomaterial to be used in TE must
meet certain fundamental characteristics to achieve success.
Figure 2. Microphotograph of the morphology of the scaffolds using scanning electron microscope (4,000 magnification). A, PLGA/
BSA/VEGF matrix; B, PLGA/BSA scaffold; C, PLGA 13% matrix. PLGA: polylactic-co-glycolic acid; BSA: bovine serum albumin; VEGF:
vascular endothelial growth factor.
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The biomaterial should be both biocompatible and biodegrad-
able, and able to support cellular adhesion and prolifera-
tion (11). It also must deliver growth factors, which are
important for tissue regeneration, permit the diffusion of
nutrients through the biomaterial and have degradation
kinetics compatible with the location of regeneration. It
should also present a tridimensional structure that can
mimic the extracellular scaffold (ECM) (12-14) and be
capable of supporting cellular adhesion and proliferation,
facilitating the contact between cells (13,15).
A further important process for TE is angiogenesis,
a complex and dynamic event that depends on the
interaction of various factors, including cell type, growth
factors, extra cellular scaffold and the biomechanical
properties of the matrices (16). Therefore, various proper-
ties of the developed scaffolds that are important for the
success of TE have been analyzed in this study.
Despite finding statistical differences between the
diameters of the PLGA/BSA scaffolds in relation to the
other groups, it is believed that there is no relevant
physiological difference in relation to the average diameter
of the fibers. The values are very similar and all groups
presented fibers on a nanometric scale, similar to the ECM,
the diameters of which range from 100 to 600 nm (17).
Figure 3. A, Loss of molecular weight evaluated by gel permeation chromatography at different periods: 0 (not submitted to the
degradation process), 7, 14, and 30 days (PLGA/BSA/VEGF, PLGA/BSA and 13% PLGA matrixes) (repeated measures with post-hoc
Bonferroni). B, Average Young’s modulus for the different scaffold groups (one-way ANOVA with post-hoc Tukey’s test). C, Contact
angle in the PLGA/BSA/VEGF, PLGA/BSA and 13% PLGA films with average values of 55.22±3.22°; 61.72±4.3° and 62.73±4.66°,
respectively (repeated measures with post-hoc Bonferroni). D, Maximum tensile strain for the different scaffold groups (one-way ANOVA
with post-hoc Tukey’s test). Data are reported as means±SD. *Po0.05 compared to 13% PLGA. PLGA: polylactic-co-glycolic acid;
BSA: bovine serum albumin; VEGF: vascular endothelial growth factor.
Table 1. Measurements of the contact angle in the PLGA/BSA/VEGF, PLGA/BSA and 13% PLGA
at different time periods in seconds (n=4).
Contact angle (o)
5 s 30 s 60 s 120 s
PLGA/BSA/VEGF 121.12±4.4 89.8±6.5 126.22±5.11 121.6±661
PLGA/BSA 103.3±6.26 102.7±7.57 101±8.64 98.7±8.94
PLGA (13%) 108.6±2.61 107.21±2.72 107.25±2.84 105.7±3.4
PLGA: polylactic-co-glycolic acid; BSA: bovine serum albumin; VEGF: vascular endothelial growth factor.
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When in contact with the cells, structures with the aforemen-
tioned characteristics allow for an elevated cellular organiza-
tion (18), reduction of the apoptosis and necrosis, and
continued cell functionality (19). Furthermore, the nanofi-
bers presented an increased number of interconnected
pores, as can be observed in the SEM images, ensuring
the tridimensional arrangement, which can not only favor
cellular migration but also guarantee the exchanges of
nutrients and metabolites with the external environment (20).
The size, number and interconnectivity of the pores of
the scaffolds are important factors in the determination
of their compatibility with the cells (21). Pore sizes with
variances of micrometer to millimeter scale greatly affect
cell migration because extremely large pores prevent
contact of the cells with the biomaterial. In contrast, pores
which are under 100 nm have a negative influence on the
diffusion of nutrients and oxygen, and the elimination of
residues. Therefore, inadequate diffusion of nutrients can
result in a reduction of cell survival and the porosity of the
biomaterial must be balanced to obtain good integration
with the cells (21). An analysis of the pore size of the three
scaffold groups showed that they were adequate for cell
cultivation because they presented intermediate pore sizes
on a micrometric scale, allowing an efficient delivery of
nutrients and oxygen, and elimination of residues.
Organic solvents, such as HFIP used in the production
of nanofiber matrices, may be harmful for the cells (22,23).
The content of the residual solvent was therefore evaluated
to determine whether the scaffolds produced by electro-
spinning can present any harmful effects for cellular
development. Analysis of the toxicity results obtained from
the cultivation of hADSCs with HFIP in the various
concentrations did not reveal any statistical difference
between the groups (10, 50, 100, 250, and 500 ppm) and
the control (0 ppm), demonstrating that higher concentra-
tions of HFIP did not result in toxicity for the cells. In this
study, the values of the solvents were 14.5, 10.4, and
29.6 ppm for the PLGA/BSA/VEGF, PLGA/BSA and 13%
PLGA matrices, respectively. Low concentrations of residual
HFIP were found in the nanofiber matrices, the values
being well below 500 ppm, which was the largest concentra-
tion tested in cellular assay with HFIP. When making a
correlation between this finding and the cytotoxicity test
with LDH dosage, it was observed that there was no
negative effect for the cells in all the analyzed matrices.
It was also observed that the dosages of LDH in all the
scaffold groups were very similar to the negative control.
These results corroborate with the results of Nam et al. (24),
who evaluated the quantity of residual HFIP in the PCL
scaffolds produced by ES. This study demonstrated that
Figure 4. A, Graph obtained by thermogravimetric analysis
showing the mean percentage of weight loss of the PLGA/BSA/
VEGF, PLGA/BSA and PLGA 13% scaffolds. B, In vitro VEGF
liberation curve from the PLGA/BSA/VEGF scaffolds. PLGA:
polylactic-co-glycolic acid; BSA: bovine serum albumin; VEGF:
vascular endothelial growth factor.
Table 2. Average quantity of residual solvent in the various scaffolds (n=3).
Scaffolds Residual solvent
Weight loss (%) Concentration of HFIP (ppm)
PLGA/BSA/VEGF 2.46±0.21 14.5±1.23
PLGA/BSA 1.5±0.22 10.4±1.52
PLGA 13% 3±0.45 29.6±4.44
PLGA: polylactic-co-glycolic acid; BSA: bovine serum albumin; VEGF: vascular
endothelial growth factor; HFIP: 1,1,1,3,3,3-hexafluoro-2-propanol.
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values of up to 250 ppm of this solvent did not result in
toxicity for the chondrocytes in vitro (24).
Degradation is an important point that should be evalu-
ated in accordance with the regeneration site. Ideally, the
degradation rate of the biomaterial should be similar to
the regeneration rate of the tissue (25). In this study, the
degradation of the three types of scaffold was approxi-
mately 25% in 30 days. It should be taken into considera-
tion that in vivo the degradation rate would probably be
higher because other plasma components could accel-
erate the process (26). Consequently, it is believed that
the produced scaffolds could be good candidates for tissue
regeneration, functioning as release devices controlled
by GFs, because after the initial burst (GFs probably
present on the surface), the liberation of the bioactive
agents occurs when the scaffolds are being degraded
(27). If the scaffolds have slow degradation, the GF will
not be released in a timely manner to promote tissue
regeneration.
Evaluation of the hydrophilicity/hydrophobicity of the
scaffolds is made by the measurement of the contact
angle. The materials are considered hydrophilic when the
measurement of the contact angle is lower than 90° and
hydrophobic when it is above 90°. Studies have demon-
strated that moderate contact angles with values between
40° and 70° are ideal for cellular adhesion (28). The contact
angle measurement was made in the three scaffold groups
and also in polymeric films produced from the same
polymeric solutions. In the temporal analysis, the three
groups demonstrated a hydrophobic profile in practically
all the evaluation time periods, with the exception of the
30-s period for the PLGA/BSA/VEGF matrices, which had
Figure 5. A, Evaluation of the metabolically active cells by MTT after cultivation in a DMEM medium with various concentrations of
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) solvent (repeated measures with post-hoc Bonferroni). B, Cellular adhesion after 6 h of
cultivation in vitro for 5 primary cultures of human adipose derived stem cells tested on the following scaffold groups: PLGA/BSA/VEGF,
PLGA/BSA, 13% PLGA and the control (cells cultivated directly on the cultivation plate wells) (one-way ANOVA with post-hoc Tukey’s
test). Data are reported as means±SE. PLGA: PLGA: polylactic-co-glycolic acid; BSA: bovine serum albumin; VEGF: vascular
endothelial growth factor.
Figure 6. Evaluation of the metabolically active cells by MTT
assay, tested on the following scaffold groups: PLGA/BSA/VEGF,
PLGA/BSA, 13% PLGA and the control (cells cultivated directly
on the cultivation well plates). Data are reported as means±SD.
*Po0.05, repeated measures with post-hoc Bonferroni. PLGA:
polylactic-co-glycolic acid; BSA: bovine serum albumin; VEGF:
vascular endothelial growth factor.
Figure 7. Dosage of lactate dehydrogenase (LDH) in supernatant
of primary cultures of human adipose derived stem cells tested on
the following scaffold groups: PLGA/BSA/VEGF, PLGA/BSA, 13%
PLGA, negative control group (cells seeded directly on the cultiva-
tion well plates) and the positive control group (Triton). Data are
reported as means±SD. *Po0.05 compared to 13% PLGA
(repeated measures with post-hoc Bonferroni). PLGA: polylactic-
co-glycolic acid; BSA: bovine serum albumin; VEGF: vascular
endothelial growth factor.
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an angle consistent with the hydrophilic material. How-
ever, this difference appears to be random because it did
not occur in the sequential time periods, in which once
again a hydrophobic profile was observed. Some studies
have demonstrated that scaffolds produced from emul-
sions present a significant reduction in the contact angle
measurement, which was not observed in this study (29,30).
One hypothesis for this fact is that materials with porous
and rough structures, such as the scaffolds produced by
electrospinning, present hydrophobic characteristics due
to the large quantity of air present in their pores (31,32).
The results obtained through the contact angle measure-
ments in films made from the same polymeric solutions
corroborate with this hypothesis, remembering that in
this case, the films presented hydrophilic characteristics.
Because greater hydrophilicity was observed in the PLGA/
BSA/VEGF films, it is suggested that the scaffolds produced
in this group present better results for cellular adhesion
as, according to former studies, the cells present greater
adhesion and growth in hydrophilic materials, which are,
therefore, the most highly recommended for use in bio-
medical applications (33–35).
The mechanical characteristics of the biomaterials are
determined by both the properties of the actual material
and its structure. The interaction of the mechanical proper-
ties of the materials with the graft setting is of utmost
importance for the progression of tissue regeneration not
to be limited by mechanical failures of the biomaterials and
for tissue regeneration to occur (7,36). In this study, the
scaffolds produced from emulsion presented a greater
Young’s modulus and also greater maximum stress and
strain. These scaffolds were shown to be more resistant
than the 13% PLGA scaffold. It is suggested that the
increase in tensile strength in the scaffolds produced from
emulsion, should be related to the presence of nanopar-
ticles of Span-80 contained in the emulsion, which may
have become attached to the nanofibers, acting as a
re-enforcement to their resistance. This result is corrobo-
rated by a previous study of Li et al., in which an increase
occurred in Young’s model in the scaffolds produced from
emulsion containing the surfactant Span-80 (29).
In relation to the incorporation rate of the GF on the
matrices, the results obtained were 3.47±0.96% (n=3).
A similar finding was observed by Chew et al., who
encountered incorporation efficiency results of 3.10% for
the neural growth factor (37). Another study using PLGA
scaffolds produced from emulsion, presented incorpora-
tion efficiency of 1.56% for the BSA (38). The low efficiency
results may have occurred due to the physicochemical
instability of the VEGF during the various processes for
the production of the scaffolds (27). Initially, the methodology
itself presented a loss of components during its execution,
attested by the formation of fibers outside the collect-
ing plate. Besides, the production of the fibers involves
stages, which can contribute to the loss of bioactivity of
the protein because of the alterations in the spatial
conformation of the protein structures in contact with the
polymeric solution. The mechanical homogenization pro-
cess of the emulsion, therefore, along with the contact with
the organic solvent and the high tension to which the
polymeric solution is submitted during the fabrication
process of the scaffold should be highlighted. There are
some strategies that have the aim of minimizing the
effects described above and which guarantee the bioac-
tivity and functionality of the GF. Among these is the
addition of surfactants, such as Span-80, used with the
objective of internalizing the aqueous fraction containing
the protein and therefore lessening the contact with the
organic solvent (29). The addition of other proteins, such
as albumin, has already been described as a stabilizer of
GFs during the ES process. In the present study, these
strategies were adopted to minimize the effects of ES on
the VEGF. Initially, albumin was added to the aqueous
solution with the objective of reducing the instability of the
bioactive molecule. Together with this, the surfactant
Span-80 was added during the oil phase of the emulsion
to lessen the exposure of the VEGF to the organic solvent,
HFIP. However, as was observed, these strategies had
little effect in obtaining a high incorporation value of the
GF. A point highlighted in the work of Chew et al. (37) to
explain the low level of incorporation encountered, which
is also applicable in the results found in the present study,
is the fact that the electrostatic forces work in a different
way in the two phases of the polymeric solution, ejecting,
therefore, the two phases with different velocities and
making it impossible to incorporate the GF with the
nanofibers (37).
However, it can be emphasized that during tissue
regeneration using MSCs, there is a paracrine action of
the latter with liberation of growth factors, among them
being VEGF. According to Parekkadan et al. (39), 106
MSCs in vitro produce approximately 100 pg GF in 24 h.
From this, it is estimated that to obtain 10,000 pg GF from
MSCs, 100 million cells would be necessary. In the present
study, the average incorporation efficiency in the PLGA/
BSA/VEGF scaffolds was approximately 3.5%, or 35,000 pg.
Considering the aforementioned facts, physiologically, the
quantity of VEGF present in the polymeric scaffold would
be equivalent to an infusion of 350 million MSCs (39).
However, despite the low incorporation efficiency rate, the
VEGF incorporated in the scaffold could be sufficient
to obtain a physiological result, which would in turn be
complemented with a local cellular secretion.
On the other hand, the PLGA/BSA/VEGF scaffolds
appeared to be good devices for the controlled liberation
of GFs. From the total VEGF incorporated in the fiber,
there was an average liberation of 91.37% in a period of
504 h (21 days) (n=3). A burst was observed in the first
8 h, with liberation increases up to 72 h, when it appeared
that a plateau was established (Figure 4B).
Cellular adhesion is the first step in a sequence of
events that direct the cellular and biomaterial interaction.
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The biomaterials should promote cellular adhesion, which
is a fundamental characteristic for cell survival, because
the absence of this contact can initiate mechanisms
of programmed cell death (40). All the scaffold groups
presented high cell adhesion values compared to the
control group. Despite the fact that there was no statistical
difference among the four evaluated groups, a tendency
for greater cell adhesion was observed in the PLGA/BSA/
VEGF group. This behavior could be related to the
fact that the films produced from the PLGA/BSA/VEGF
polymeric solution presented a higher hydrophilic profile
and were also more adept for cellular adhesion. Further-
more, the GFs have a leading role in cell behavior.
Adhesion, proliferation and differentiation are to a greater
extent dictated by the presence of GFs, which are soluble
in the ECM (17). The VEGF present in the scaffolds may
have increased the bioactivity of the PLGA/BSA/VEGF
scaffold and, consequently, supported cellular adhesion in
the latter.
Although the use of emulsions is widely discussed in
the literature, there are still questions concerning the possible
negative effect on the growth of cells cultivated in scaffolds
containing surfactants, as for example Span-80 (29). Cells
cultivated on scaffolds produced by emulsion present
similar growth to the 13% PLGA control group prepared
with just the PLGA polymer dissolved in HFIP. The
proliferation rate was very similar amongst all the groups,
including the control (cells seeded directly onto the wells).
This latter group presented the lowest proliferation rate
compared to the other groups. It can be concluded, therefore,
that cells seeded on the scaffolds performed better
compared to the control; however, because of the longer
period required for the adaption of the latter with the
polymeric matrices, cells did not reach the same level as
the cells that were seeded directly on the culture wells in
the same period of analysis. Similar results were found by
Steffens et al. (19) when cultivating MSCs on PDLLA and
PDLLA/Spirulina scaffolds.
Regarding viability in relation to the time of cultivation,
it was observed that there was a higher number of metaboli-
cally active cells on the 14th day (Po0.001) compared to
the other time periods, with the exception of the 21st day
of analysis, in which there was no statistical difference
(P=1.000). Through microscope analysis, saturation of
the well culture could be observed after the 14th day of
cultivation. In other words, the cells no longer possessed
physical space for their multiplication.
In the present study, cellular toxicity was evaluated
through dosages of the enzyme LDH, which is found in
practically all organs and tissue of the organism. The
increase in the extracellular concentration of this enzyme
is proportional with the increase in cell death (19). In this
assay, it was observed that the three types of scaffolds
did not have cytotoxicity for the hADSCs because all
presented much lower dosages of LDH compared to the
positive control. During the period of analysis, the highest
dosage level of the enzyme LDH (Po0.05) was found on
the 21st day, suggesting greater cell death. This finding
can be correlated with the reduction of cellular metabolism
between the 14th and 21st day of cellular cultivation,
which was observed by the MTT assay, as well as the
greater number of cells, when compared to the other days
of analysis.
The scaffolds developed from emulsion presented
well-distributed, smooth fibers on a nanometric scale with
a porous structure similar to that of the ECM of the cells.
They presented appropriate characteristics for cell cultiva-
tion when applied to TE. These scaffolds have been
shown to be safe for pre-clinical use because scaffolds
produced by emulsion ES with or without VEGF have
been shown to be non-toxic for stem cells. A proliferation
rate has also been verified, which was similar among the
three scaffold groups with the PLGA/BSA/VEGF scaffold
presenting a higher proliferation rate, suggesting a contribu-
tion from the GFs. Furthermore, the scaffolds degraded
during the period of study, which is an ideal characteristic
for release devices applied to TE.
The scaffolds containing VEGF presented liberation
supported by GFs, which is a fundamental requisite for
materials for in vivo implantation. Despite the efficiency
of the GF incorporation by the emulsion electrospinning
technique not being high, it is hoped that the quantity
of VEGF incorporated in the scaffolds will be sufficient to
contribute to tissue regeneration because these mole-
cules operate in greatly reduced concentrations in the
organism. It is recommended that this be clarified by
in vivo assays.
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